| Individualized Antiplatelet Therapy: A Long Way to Go | |
| Alternative Title | Individualized Antiplatelet Therapy: A Long Way to Go |
| Han YaLing | |
| 2018 | |
| Source Publication | Chinese Medical Journal
 |
| ISSN | 0366-6999 |
| Volume | 131Issue:12Pages:1387-1389 |
| Other Abstract | Antiplatelet therapy is the cornerstone for the management of patients with coronary artery disease. In the past two decades, the study on individualized antiplatelet therapy has never been more prosperous accompanied with the rapid growth of percutaneous coronary interventions (PCIs). |
| Keyword | Acute Coronary Syndrome Medicine R Antiplatelet Therapy Cardiovascular Disease Percutaneous Coronary Intervention |
| Indexed By | CSCD |
| Language | 英语 |
| CSCD ID | CSCD:6266036 |
| Citation statistics | |
| Document Type | 期刊论文 |
| Identifier | http://ir.imr.ac.cn/handle/321006/143371 |
| Collection | 中国科学院金属研究所 |
| Affiliation | 中国科学院金属研究所 |
| Recommended Citation GB/T 7714 | Han YaLing. Individualized Antiplatelet Therapy: A Long Way to Go[J]. Chinese Medical Journal,2018,131(12):1387-1389. |
| APA | Han YaLing.(2018).Individualized Antiplatelet Therapy: A Long Way to Go.Chinese Medical Journal,131(12),1387-1389. |
| MLA | Han YaLing."Individualized Antiplatelet Therapy: A Long Way to Go".Chinese Medical Journal 131.12(2018):1387-1389. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment